Multi-center randomized open label phase II trial on three rituximab dosing schemes in immune thrombocytopenia patients

Autor: Zwaginga, J.J., Holt, B. van der, Boekhorst, P.A. te, Biemond, B.J., Levin, M.D., Griend, R. van der, Brand, A., Zweegman, S., Pruijt, H.F.M., Novotny, V.M.J., Vreugdenhil, A., Groot, M.R. de, Weerdt, O. de, Pampus, E.C.M. van, Maanen-Lamme, T.M. van, Wittebol, S., Schipperus, M.R., Silbermann, M.H., Huijgens, P.C., Luten, M., Hollestein, R., Brakenhoff, J.A.C., Schrama, J.G., Valster, F.A.A., Velders, G.A., Koene, H.R., Dutch HOVON 64 Study Grp

Publikováno v: Zwaginga, JJ, van der Holt, B, te Boekhorst, P A, Biemond, B J, Levin, M D, van der Griend, R, Brand, A, Zweegman, S, Pruijt, H F M, Novotny, V M J, Vreugdenhil, A, de Groot, M R, de Weerdt, O, van Pampus, E C M, van Maanen-Lamme, T M, Wittebol, S, Schipperus, M R, Silbermann, M H, Huijgens, P C, Luten, M, Hollestein, R, Brakenhoff, J A C, Schrama, J G, Valster, F A A, Velders, G A & Koene, H R 2015, ' Multi-center randomized open label phase II trial on three rituximab dosing schemes in immune thrombocytopenia patients ', Haematologica, vol. 100, no. 3, pp. E90-E92 . https://doi.org/10.3324/haematol.2014.110213
Haematologica, 100, e90-2
Haematologica, 100, 3, pp. e90-2
Haematologica-the Hematology Journal, 100(3), E90-E92. Ferrata Storti Foundation
Haematologica, 100(3), E90-E92
Haematologica, 100(3), E90-E92. Ferrata Storti Foundation
Haematologica, 100(3), e90-e92. Ferrata Storti Foundation

The overall short-term treatment efficacy of rituximab (R) in immune thrombocytopenia (ITP) is reported to be approximately 58%.[1][1],[2][2] With four once-weekly 375 mg/m2 doses, responses of 31% after two years,[2][2] and 21% after five years[2][2

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf58d4b2021439809e6420cdc02f1765
https://doi.org/10.3324/haematol.2014.110213

Clinical effectiveness of leucoreduced, pooled donor platelet concentrates, stored in plasma or additive solution with and without pathogen reduction

Autor: Kerkhoffs, J.L.H., Putten, W.L.J. van, Novotny, V.M.J., Boekhorst, P.A.W.T., Schipperus, M.R., Zwaginga, J.J., Pampus, L.C.M. van, Greef, G.E. de, Luten, M., Huijgens, P.C., Brand, A., Rhenen, D.J. van, Dutch Belgian HOVON Cooperative Gr

Publikováno v: British Journal of Haematology, 150(2), 209-217

P>Pathogen reduction (PR) of platelet products increases costs and available clinical studies are equivocal with respect to clinical and haemostatic effectiveness. We conducted a multicentre, open-label, randomized, non-inferiority trial comparing th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::66d9ecabf2209b783474bdc0155b9dd7
http://hdl.handle.net/1887/108617

Survival of the fittest?--survival of stored red blood cells after transfusion

Autor: Luten, M., Roerdinkholder-Stoelwinder, B., Bost, H.J., Bosman, G.J.C.G.M.

Publikováno v: Cellular and Molecular Biology, Including Cyto-Enzymology, 50, 197-203
Cellular and Molecular Biology, Including Cyto-Enzymology, 50, 2, pp. 197-203

Item does not contain fulltext During the last 90 years many developments have taken place in the world of blood transfusion. Several anticoagulants and storage solutions have been developed. Also the blood processing has undergone many changes. At t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::3f4260bee1a147d605b42f5b7eec9c64
http://hdl.handle.net/2066/57694

Short-term and long-term survival of transfused RBCS: A comparison between stored rcc of short and long shelf life

Autor: Luten, M., Roerdinkholder-Stoelwinder, B., Nicolaas Schaap, Curvers, J., Best, H. J., Grip, W. J., Bosman, G. J. C. G. M.

Publikováno v: ResearcherID

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::05adcb19b4c92e5baf6a62b05f1ef567
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000239999300795&KeyUID=WOS:000239999300795

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.